A Patent Ductus Arteriosus Severity Score Predicts Chronic Lung Disease or Death before Discharge

Journal of Pediatrics

Volumn 167, Issue 6, 2015, Pages 1354-1361.e2

  EL Khuffash, Afif ^a,b   James, Adam T ^a   Corcoran, John David ^a,b   Dicker, Patrick ^b   Franklin, Orla ^c   Elsayed, Yasser N ^d   Ting, Joseph Y ^e   Sehgal, Arvind ^f,g   Malikiwi, Andra ^f   Harabor, Andrei ^h   Soraisham, Amuchou S ^h   McNamara, Patrick J ^i,j  

^a ROTUNDA HOSPITAL   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^d UNIVERSITY OF MANITOBA   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f MONASH CHILDREN S HOSPITAL   (Australia)

^g MONASH UNIVERSITY   (Australia)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; CANADA; CAUSE OF DEATH; CHRONIC DISEASE; CLINICAL TRIAL; COMPLICATION; DOPPLER ECHOCARDIOGRAPHY; DUCTUS ARTERIOSUS, PATENT; EPIDEMIOLOGY; FEMALE; HOSPITAL DISCHARGE; HUMAN; INFANT; INFANT MORTALITY; IRELAND; LUNG DISEASES; MALE; MORTALITY; MULTICENTER STUDY; NEWBORN; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; TRENDS;

AUSTRALIA; CANADA; CAUSE OF DEATH; CHRONIC DISEASE; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HOSPITAL MORTALITY; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; IRELAND; LUNG DISEASES; MALE; PATIENT DISCHARGE; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 85027929316     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2015.09.028     Document Type: Article

References (26)

1. Evans, N., Preterm patent ductus arteriosus: a continuing conundrum for the neonatologist?. Semin Fetal Neonatal Med 20 (2015), 272–277.
2. Cooke, L., Steer, P., Woodgate, P., Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev(2), 2003, CD003745.
3. El-Khuffash, A.F., Slevin, M., McNamara, P.J., Molloy, E.J., Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants. Arch Dis Child Fetal Neonatal Ed 96 (2011), 133–137.
4. Cunha, G.S., Mezzacappa-Filho, F., Ribeiro, J.D., Risk factors for bronchopulmonary dysplasia in very low birth weight newborns treated with mechanical ventilation in the first week of life. J Trop Pediatr 51 (2005), 334–340.
5. Shortland, D.B., Gibson, N.A., Levene, M.I., Archer, L.N., Evans, D.H., Shaw, D.E., Patent ductus arteriosus and cerebral circulation in preterm infants. Dev Med Child Neurol 32 (1990), 386–393.
6. Van Overmeier, B., Patent ductus arteriosus: how aggressive should we be?. Neonatology, 91, 2007, 318.
7. Brooks, J.M., Travadi, J.N., Patole, S.K., Doherty, D.A., Simmer, K., Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 90 (2005), 235–239.
8. El-Khuffash, A., Barry, D., Walsh, K., Davis, P.G., Molloy, E.J., Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage. Arch Dis Child Fetal Neonatal Ed 93 (2008), F407–F412.
9. Schena, F., Francescato, G., Cappelleri, A., Picciolli, I., Mayer, A., Mosca, F., et al. Association between hemodynamically significant patent ductus arteriosus and bronchopulmonary dysplasia. J Pediatr 166 (2015), 1488–1492.
10. Chang, L.Y., McCurnin, D., Yoder, B., Shaul, P.W., Clyman, R.I., Ductus arteriosus ligation and alveolar growth in preterm baboons with a patent ductus arteriosus. Pediatr Res 63 (2008), 299–302.
11. Zonnenberg, I., de Waal, K., The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review. Acta Paediatr 101 (2012), 247–251.
12. Papile, L.A., Burstein, J., Burstein, R., Koffler, H., Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J Pediatr 92 (1978), 529–534.
13. Mertens, L., Seri, I., Marek, J., Arlettaz, R., Barker, P., McNamara, P., et al. Targeted Neonatal echocardiography in the neonatal intensive care unit: practice guidelines and recommendations for training writing group of the American Society of Echocardiography (ASE) in collaboration with the European Association of Echocardiography (EAE) and the Association for European Pediatric Cardiologists (AEPC). J Am Soc Echocardiogr 24 (2011), 1057–1078.
14. El-Khuffash, A.F., McNamara, P.J., Neonatologist-performed functional echocardiography in the neonatal intensive care unit. Semin Fetal Neonatal Med 16 (2011), 50–60.
15. James, A.T., Corcoran, J.D., Jain, A., McNamara, P.J., Mertens, L., Franklin, O., et al. Assessment of myocardial performance in preterm infants less than 29 weeks gestation during the transitional period. Early Hum Dev 90 (2014), 829–835.
16. Harrell, F.E. Jr., Lee, K.L., Mark, D.B., Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996), 361–387.
17. Schmidt, B., Roberts, R.S., Fanaroff, A., Davis, P., Kirpalani, H.M., Nwaesei, C., et al. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr 148 (2006), 730–734.
18. McNamara, P.J., Sehgal, A., Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed 92 (2007), 424–427.
19. Youn, Y., Lee, J.Y., Lee, J.H., Kim, S.Y., Sung, I.K., Lee, J.Y., Impact of patient selection on outcomes of PDA in very low birth weight infants. Early Hum Dev 89 (2013), 175–179.
20. Alagarsamy, S., Chhabra, M., Gudavalli, M., Nadroo, A.M., Sutija, V.G., Yugrakh, D., Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants. J Perinat Med 33 (2005), 161–164.
21. Sehgal, A., Paul, E., Menahem, S., Functional echocardiography in staging for ductal disease severity: role in predicting outcomes. Eur J Pediatr 172 (2013), 179–184.
22. Sellmer, A., Bjerre, J.V., Schmidt, M.R., McNamara, P.J., Hjortdal, V.E., Host, B., et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3. Arch Dis Child Fetal Neonatal Ed 98 (2013), 505–510.
23. Weisz, D.E., More, K., McNamara, P.J., Shah, P.S., PDA ligation and health outcomes: a meta-analysis. Pediatrics 133 (2014), 1024–1046.
24. El-Khuffash, A., James, A.T., Cleary, A., Semberova, J., Franklin, O., Miletin, J., Late medical therapy of patent ductus arteriosus using intravenous paracetamol. Arch Dis Child Fetal Neonatal Ed 100 (2015), 253–256.
25. Guyatt, G.H., Kirshner, B., Jaeschke, R., Measuring health status: what are the necessary measurement properties?. J Clin Epidemiol 45 (1992), 1341–1345.
26. Dokainish, H., Left ventricular diastolic function and dysfunction: central role of echocardiography. Glob Cardiol Sci Pract, 2015, 2015, 3.